Xiang Le-Yang, Ou Huo-Hui, Chen Zhan-Jun, Fang Ying-Hao, Huang Yu, Li Xiang-Hong, Yang Ding-Hua
Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. E-mail:
Nan Fang Yi Ke Da Xue Xue Bao. 2017 Aug 20;37(8):1071-1077. doi: 10.3969/j.issn.1673-4254.2017.08.12.
To investigate the expression of Wnt5b in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) tissues and its correlation with the clinicopathological parameters.
Quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemical staining were employed to measure Wnt5b mRNA and protein expressions in two groups of HBV-related HCC patients (100 cases in each) selected from a cohort of 289 cases with HBV-related HCC using simple random sampling method. The correlation of Wnt5b expression with the clinicopathological parameters and the prognosis of HCC patients was analyzed.
Wnt5b mRNA expression was significantly higher in HCC tissues than that of adjacent noncancerous tissues in 65.0% (65/100) of the cases, and the positivity rate of Wnt5b protein was significantly higher in HCC tissues than that of adjacent noncancerous tissues (58.0% vs 22.0%, P<0.05). Wnt5b expression was significantly correlated with the tumor size (P<0.05), tumor number (P<0.01, only at the protein level), tumor differentiation (P<0.01, only at the protein level), TNM stage (P<0.05), BCLC stage (P<0.05), metastasis (P<0.05) and recurrence (P<0.01). The patients with up-regulated Wnt5b mRNA and protein had a shorter relapse-free survival (P<0.01).
s Up-regulated Wnt5b might contribute to the progression of HBV-related HCC and predicts a poor prognosis.
探讨Wnt5b在乙型肝炎病毒(HBV)相关肝细胞癌(HCC)组织中的表达及其与临床病理参数的相关性。
采用简单随机抽样法,从289例HBV相关HCC患者队列中选取两组HBV相关HCC患者(每组100例),运用定量实时聚合酶链反应(qRT-PCR)和免疫组织化学染色检测Wnt5b mRNA和蛋白表达。分析Wnt5b表达与临床病理参数及HCC患者预后的相关性。
65.0%(65/100)的病例中,HCC组织中Wnt5b mRNA表达显著高于癌旁非癌组织,HCC组织中Wnt5b蛋白阳性率显著高于癌旁非癌组织(58.0%对22.0%,P<0.05)。Wnt5b表达与肿瘤大小(P<0.05)、肿瘤数目(P<0.01,仅在蛋白水平)、肿瘤分化(P<0.01,仅在蛋白水平)、TNM分期(P<0.05)、BCLC分期(P<0.05)、转移(P<0.05)和复发(P<0.01)显著相关。Wnt5b mRNA和蛋白上调的患者无复发生存期较短(P<0.01)。
Wnt5b上调可能促进HBV相关HCC的进展并预示预后不良。